• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症相关间质性肺疾病的诊断和预后临床算法。

Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.

机构信息

Department of Internal Medicine, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil; Division of Rheumatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

Division of Rheumatology, Hospital Nossa Senhora da Conceição, Grupo Hospitalar Conceição, Porto Alegre, Brazil.

出版信息

Semin Arthritis Rheum. 2017 Oct;47(2):228-234. doi: 10.1016/j.semarthrit.2017.03.019. Epub 2017 Apr 1.

DOI:10.1016/j.semarthrit.2017.03.019
PMID:28454677
Abstract

INTRODUCTION

Interstitial lung disease (ILD) is currently the primary cause of death in systemic sclerosis (SSc). Thoracic high-resolution computed tomography (HRCT) is considered the gold standard for diagnosis. Recent studies have proposed several clinical algorithms to predict the diagnosis and prognosis of SSc-ILD.

OBJECTIVE

To test the clinical algorithms to predict the presence and prognosis of SSc-ILD and to evaluate the association of extent of ILD with mortality in a cohort of SSc patients.

METHODS

Retrospective cohort study, including 177 SSc patients assessed by clinical evaluation, laboratory tests, pulmonary function tests, and HRCT. Three clinical algorithms, combining lung auscultation, chest radiography, and percentage predicted forced vital capacity (FVC), were applied for the diagnosis of different extents of ILD on HRCT. Univariate and multivariate Cox proportional models were used to analyze the association of algorithms and the extent of ILD on HRCT with the risk of death using hazard ratios (HR).

RESULTS

The prevalence of ILD on HRCT was 57.1% and 79 patients died (44.6%) in a median follow-up of 11.1 years. For identification of ILD with extent ≥10% and ≥20% on HRCT, all algorithms presented a high sensitivity (>89%) and a very low negative likelihood ratio (<0.16). For prognosis, survival was decreased for all algorithms, especially the algorithm C (HR = 3.47, 95% CI: 1.62-7.42), which identified the presence of ILD based on crackles on lung auscultation, findings on chest X-ray, or FVC <80%. Extensive disease as proposed by Goh et al. (extent of ILD > 20% on HRCT or, in indeterminate cases, FVC < 70%) had a significantly higher risk of death (HR = 3.42, 95% CI: 2.12-5.52). Survival was not different between patients with extent of 10% or 20% of ILD on HRCT, and analysis of 10-year mortality suggested that a threshold of 10% may also have a good predictive value for mortality. However, there is no clear cutoff above which mortality is sharply increased.

CONCLUSION

Clinical algorithms had a good diagnostic performance for extents of SSc-ILD on HRCT with clinical and prognostic relevance (≥10% and ≥20%), and were also strongly related to mortality. Non-HRCT-based algorithms could be useful when HRCT is not available. This is the first study to replicate the prognostic algorithm proposed by Goh et al. in a developing country.

摘要

简介

间质性肺病(ILD)是目前系统性硬化症(SSc)患者死亡的主要原因。胸部高分辨率计算机断层扫描(HRCT)被认为是诊断ILD 的金标准。最近的研究提出了几种临床算法来预测 SSc-ILD 的诊断和预后。

目的

检测预测 SSc-ILD 存在和预后的临床算法,并评估ILD 程度与 SSc 患者死亡率之间的关系。

方法

回顾性队列研究,纳入 177 例接受临床评估、实验室检查、肺功能检查和 HRCT 的 SSc 患者。应用三种临床算法,结合肺部听诊、胸部 X 线和预计用力肺活量(FVC)百分比,对 HRCT 上不同程度的ILD 进行诊断。采用单变量和多变量 Cox 比例模型,使用风险比(HR)分析算法和 HRCT 上ILD 程度与死亡风险的相关性。

结果

HRCT 上ILD 的患病率为 57.1%,中位随访 11.1 年后 79 例患者死亡(44.6%)。对于识别 HRCT 上ILD 程度≥10%和≥20%,所有算法的敏感性均较高(>89%),而阴性似然比均较低(<0.16)。对于预后,所有算法的生存率均下降,尤其是算法 C(HR=3.47,95%CI:1.62-7.42),该算法根据肺部听诊的爆裂声、胸部 X 线检查结果或 FVC<80%来识别ILD 的存在。Goh 等人提出的广泛疾病(HRCT 上ILD 程度>20%或不确定病例 FVC<70%)的死亡风险显著更高(HR=3.42,95%CI:2.12-5.52)。HRCT 上ILD 程度为 10%或 20%的患者之间的生存率无差异,10 年死亡率分析表明,10%的阈值可能对死亡率也有较好的预测价值。但是,没有明确的截止值以上死亡率急剧增加。

结论

临床算法对 HRCT 上 SSc-ILD 程度具有良好的诊断性能,且具有临床和预后相关性(≥10%和≥20%),并且与死亡率密切相关。在无法进行 HRCT 时,基于非 HRCT 的算法可能有用。这是首次在发展中国家复制 Goh 等人提出的预后算法的研究。

相似文献

1
Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.系统性硬化症相关间质性肺疾病的诊断和预后临床算法。
Semin Arthritis Rheum. 2017 Oct;47(2):228-234. doi: 10.1016/j.semarthrit.2017.03.019. Epub 2017 Apr 1.
2
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis.用于预测系统性硬化症中存在间质性肺病的临床决策规则。
Arthritis Care Res (Hoboken). 2012 Apr;64(4):519-24. doi: 10.1002/acr.21583.
3
Interstitial lung disease in systemic sclerosis: a simple staging system.系统性硬化症中的间质性肺疾病:一种简易分期系统。
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi: 10.1164/rccm.200706-877OC. Epub 2008 Mar 27.
4
Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.简报:肺功能检查:在硬皮病相关间质性肺病的早期检测和筛查中,存在大量假阴性结果。
Arthritis Rheumatol. 2015 Dec;67(12):3256-61. doi: 10.1002/art.39405.
5
Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.用力肺活量和肺弥散切点在系统性硬化症相关间质性肺病中的表现。
J Rheumatol. 2018 Nov;45(11):1572-1576. doi: 10.3899/jrheum.171362. Epub 2018 Oct 1.
6
KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD).KL6 和 IL-18 水平与系统性硬化症相关间质性肺病(SSc-ILD)患者的呼吸功能测试和 HRCT 评估的间质性肺病程度呈负相关。
Semin Arthritis Rheum. 2024 Apr;65:152366. doi: 10.1016/j.semarthrit.2024.152366. Epub 2024 Jan 13.
7
Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.胸膜不规则,一种用于研究系统性硬化症和抗合成酶综合征间质性肺疾病的新超声征象。
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S136-41. Epub 2015 Aug 27.
8
Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.硬皮病相关肺疾病中的合并性肺纤维化和肺气肿对肺生理学和肺动脉高压筛查有重大的混杂影响。
Arthritis Rheumatol. 2016 Apr;68(4):1004-12. doi: 10.1002/art.39528.
9
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.系统性硬化症的间质性肺疾病:来自西班牙硬皮病研究组的数据。
Rheumatol Int. 2018 Mar;38(3):363-374. doi: 10.1007/s00296-017-3916-x. Epub 2018 Jan 10.
10
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.候选血清生物标志物在系统性硬化症相关间质性肺病中的表现。
Arthritis Rheumatol. 2019 Jun;71(6):972-982. doi: 10.1002/art.40815. Epub 2019 Apr 26.

引用本文的文献

1
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.间质性肺异常的评估与管理方法:美国胸科学会官方临床声明
Am J Respir Crit Care Med. 2025 Jul;211(7):1132-1155. doi: 10.1164/rccm.202505-1054ST.
2
An exploratory analysis of differences in serum protein expression by sex in patients with systemic sclerosis associated interstitial lung disease.系统性硬化症相关间质性肺疾病患者血清蛋白表达性别差异的探索性分析。
BMC Pulm Med. 2025 Jan 13;25(1):16. doi: 10.1186/s12890-024-03474-z.
3
Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.
系统性硬皮病相关间质性肺病疾病严重程度、临床病程和结局的判断异质性:系统文献回顾。
RMD Open. 2023 Nov;9(4). doi: 10.1136/rmdopen-2023-003426.
4
Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study.系统性硬皮病相关间质性肺病患者在肺移植等待名单中的预后:一项回顾性研究。
Sci Rep. 2023 Jun 22;13(1):10150. doi: 10.1038/s41598-023-37141-w.
5
Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease.系统性硬皮病相关间质性肺病患者疾病进展的蛋白生物标志物。
Sci Rep. 2023 May 27;13(1):8645. doi: 10.1038/s41598-023-35840-y.
6
Diagnosing lung involvement in inflammatory rheumatic diseases-Where do we currently stand?诊断炎症性风湿性疾病中的肺部受累——我们目前的进展如何?
Front Med (Lausanne). 2023 Jan 11;9:1101448. doi: 10.3389/fmed.2022.1101448. eCollection 2022.
7
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction.硬皮病微血管损伤与内脏器官受累之间的相关性:聚焦于肺损伤与内皮功能障碍
Diagnostics (Basel). 2022 Dec 25;13(1):55. doi: 10.3390/diagnostics13010055.
8
Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases.评估一种潜在的筛查工具在炎症性风湿性疾病发病时检测早期间质性肺病的诊断价值。
Arthritis Res Ther. 2022 May 12;24(1):107. doi: 10.1186/s13075-022-02786-x.
9
Circulating biomarkers of systemic sclerosis - interstitial lung disease.系统性硬化症-间质性肺病的循环生物标志物
J Scleroderma Relat Disord. 2020 Mar;5(2 Suppl):41-47. doi: 10.1177/2397198319894851. Epub 2020 Jan 6.
10
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients.高分辨率计算机断层扫描:改善系统性硬化症相关间质性肺病患者护理中的利弊
Diagnostics (Basel). 2021 Oct 22;11(11):1960. doi: 10.3390/diagnostics11111960.